Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Bartsch

Showing results (231-240 of 332) with videos related to

Pageof 34
Sort By:
Cancers|August 26, 2022
Frequency and Prognostic Significance of Intertumoural Heterogeneity in Multifocal Jejunoileal Neuroendocrine TumoursMoritz Jesinghaus, Jelte Poppinga, Bettina Lehman, et al.
Annals of Surgery|December 26, 2001
p16INK4a is a prognostic marker in resected ductal pancreatic cancer: an analysis of p16INK4a, p53, MDM2, an RbBerthold Gerdes, Annette Ramaswamy, Andreas Ziegler, et al.
Plos One|January 26, 2023
Proteomics biomarker discovery for individualized prevention of familial pancreatic cancer using statistical learningChung Shing Rex Ha, Martina Müller-Nurasyid, Agnese Petrera, et al.
Clinical Endocrinology|June 26, 2007
Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriersAndreas Machens, Ludwig Schaaf, Wolfram Karges, et al.
Langenbeck'S Archives of Surgery|December 29, 2011
Clinical impact of TP53 alterations in adrenocortical carcinomasJens Waldmann, Nikolaos Patsalis, Volker Fendrich, et al.
Clinical Endocrinology|January 28, 2021
Gastric enterochromaffin-like cell changes in multiple endocrine neoplasia type 1Jerena Manoharan, Martin Anlauf, Max B Albers, et al.
Cancers|November 27, 2021
Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer-A New Diagnostic and Therapeutic Target?Sabine Wächter, Pietro Di Fazio, Elisabeth Maurer, et al.
Endocrine Pathology|August 20, 2025
Exploring Intratumoral Heterogeneity in Mixed Neuroendocrine-Nonneuroendocrine Neoplasms with Spatial Transcriptomics: Even More Diverse Than AnticipatedAnnika Weiß, Julia Teply-Szymanski, Maxime Schmitt, et al.
Journal of Cellular and Molecular Medicine|March 11, 2015
IGF-1 drives chromogranin A secretion via activation of Arf1 in human neuroendocrine tumour cellsChristin Münzberg, Katharina Höhn, Denis Krndija, et al.
World Journal of Surgery|January 3, 2019
Chemoprevention with Somatuline© Delays the Progression of Pancreatic Neuroendocrine Neoplasms in a Mouse Model of Multiple Endocrine Neoplasia Type 1 (MEN1)Caroline L Lopez, Barbara Joos, Detlef K Bartsch, et al.
Pageof 34

Showing results (231-240 of 332) with videos related to

Sort By:
Pageof 34
Cancers|August 26, 2022
Frequency and Prognostic Significance of Intertumoural Heterogeneity in Multifocal Jejunoileal Neuroendocrine TumoursMoritz Jesinghaus, Jelte Poppinga, Bettina Lehman, et al.
Annals of Surgery|December 26, 2001
p16INK4a is a prognostic marker in resected ductal pancreatic cancer: an analysis of p16INK4a, p53, MDM2, an RbBerthold Gerdes, Annette Ramaswamy, Andreas Ziegler, et al.
Plos One|January 26, 2023
Proteomics biomarker discovery for individualized prevention of familial pancreatic cancer using statistical learningChung Shing Rex Ha, Martina Müller-Nurasyid, Agnese Petrera, et al.
Clinical Endocrinology|June 26, 2007
Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriersAndreas Machens, Ludwig Schaaf, Wolfram Karges, et al.
Langenbeck'S Archives of Surgery|December 29, 2011
Clinical impact of TP53 alterations in adrenocortical carcinomasJens Waldmann, Nikolaos Patsalis, Volker Fendrich, et al.
Clinical Endocrinology|January 28, 2021
Gastric enterochromaffin-like cell changes in multiple endocrine neoplasia type 1Jerena Manoharan, Martin Anlauf, Max B Albers, et al.
Cancers|November 27, 2021
Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer-A New Diagnostic and Therapeutic Target?Sabine Wächter, Pietro Di Fazio, Elisabeth Maurer, et al.
Endocrine Pathology|August 20, 2025
Exploring Intratumoral Heterogeneity in Mixed Neuroendocrine-Nonneuroendocrine Neoplasms with Spatial Transcriptomics: Even More Diverse Than AnticipatedAnnika Weiß, Julia Teply-Szymanski, Maxime Schmitt, et al.
Journal of Cellular and Molecular Medicine|March 11, 2015
IGF-1 drives chromogranin A secretion via activation of Arf1 in human neuroendocrine tumour cellsChristin Münzberg, Katharina Höhn, Denis Krndija, et al.
World Journal of Surgery|January 3, 2019
Chemoprevention with Somatuline© Delays the Progression of Pancreatic Neuroendocrine Neoplasms in a Mouse Model of Multiple Endocrine Neoplasia Type 1 (MEN1)Caroline L Lopez, Barbara Joos, Detlef K Bartsch, et al.
Pageof 34